By using HPAFII cells which had robust resistance to CAR T cell killing, we identified elevated ICAM-1, CXCL10, and CXCL11, which were associated with IFN signaling and primarily produced by PDA cells. The gene discussed is CXCL11; the disease is Patent ductus arteriosus.